Retrospective analysis of radium-223 treatment for adults with progressive castration-resistant metastatic prostate cancer with symptomatic bone metastasis. (February 2017) - Gaffney, J.; O'Boyle, G.; Gaffney, B.; Roshan, D.; Sullivan, F.; Ibrahim, N.; Martin, J.; Small, C.